Makro-Albumon

Human Albumin Macroaggregates, the active ingredient in Makro-Albumon, is an albumin drug presented as an injectable formulation for intravenous use. It is employed primarily in diagnostic imaging to assess pulmonary perfusion and related conditions. GNH USA supplies Makro-Albumon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Makro-Albumon is used in nuclear medicine procedures that evaluate pulmonary blood flow and related disorders. - Lung perfusion imaging: enables visualization of regional pulmonary blood flow for diagnostic assessment. - Pulmonary embolism detection: assists in identifying embolic obstruction of pulmonary arteries. - Pre‑operative lung function evaluation: provides functional information to guide surgical planning.

Makro-Albumon may be associated with a range of adverse reactions following intravenous administration.

Common Side Effects: - Transient fever: mild temperature rise shortly after injection. - Mild hypotension: temporary drop in blood pressure. - Headache: short‑lasting discomfort. - Nausea: occasional feeling of queasiness. - Injection site discomfort: mild pain or irritation. - Flushing: brief redness of skin.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Severe hypotension: marked blood pressure decline with possible syncope. - Pulmonary hypertension: abrupt increase in pulmonary arterial pressure. - Embolic complications: rare lodging of particles causing vascular blockage. - Acute respiratory distress: sudden breathing difficulty. - Cardiovascular collapse: life‑threatening circulatory failure.

Prior to using Makro-Albumon, clinicians should consider several safety measures. - Allergy assessment: verify no known hypersensitivity to human albumin or related proteins. - Cardiac evaluation: avoid in patients with severe heart failure or uncontrolled hypertension. - Pulmonary status: contraindicated in severe pulmonary hypertension or acute respiratory distress. - Volume monitoring: watch for signs of fluid overload, especially when combined with other albumin products. - Concurrent radiopharmaceuticals: ensure appropriate timing to prevent imaging interference. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the vial.

Makro-Albumon may interact with other agents administered intravenously.

Major Interactions (Avoid): - Other intravenous albumin solutions: risk of volume overload and circulatory strain. - High‑dose diuretics: may exacerbate hypotension.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., heparin, warfarin): potential alteration of bleeding risk. - Beta‑blockers: additive effect on blood pressure reduction. - Vasodilators (e.g., nitroglycerin): increased likelihood of hypotensive episodes. - Radiopharmaceuticals with overlapping emission spectra: may affect imaging interpretation.